Hosted by Member of the European Parliament Mr Tiemo Wölken (S&D, DE), Vice-Chair of MEP Interest Group on AMR, Member of the ENVI Committee
Co-organised by the PA International Foundation and The Parliament Magazine
Date and time: Thursday 4 June 2020 12:00-13:00 CET
Agenda:
12:00 Welcome and introduction, by Mr Tiemo Wölken, MEP*
12:05 AMR Market Failure – An EU State-Owned Enterprise? by Lord Jim O’Neill*, Chairman, UK Review on Antimicrobial Resistance 2014-2016; Former Chief Economist of Goldman Sachs
12:15 Panel introduced and chaired by Mr Tiemo Wölken, MEP*
12:18 How to Avoid a World without Antibiotics: Pre-Competitive Action through the European Lead Factory, by Dr Jon de Vlieger*, Coordinator, European Lead Factory; Director Business Development, Lygature Foundation
12:24 Crucial Role of SMEs in AMR R&D, by Dr Marc Gitzinger*, Vice-President of the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance; CEO of BioVersys
12:30 Phages to Combat AMR, by Dr Jean-Paul Pirnay*, Head of the Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Belgium; Executive Board Member of P.H.A.G.E.
12:36 Comments by senior representatives of DG SANTE and DG RTD
12.46 Q&A, chaired by Mr Tiemo Wölken, MEP*
12:55 Closing remarks by Mr Tiemo Wölken, MEP*
*confirmed